[{"address1": "3300 Nacogdoches Road", "address2": "Suite 216", "city": "San Antonio", "state": "TX", "zip": "78217", "country": "United States", "phone": "210 698 5334", "website": "https://www.bioaffinitytech.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.", "fullTimeEmployees": 57, "companyOfficers": [{"maxAge": 1, "name": "Mr. Steven  Girgenti", "age": 78, "title": "Founder & Executive Chairman of the Board", "yearBorn": 1946, "fiscalYear": 2024, "totalPay": 115430, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maria  Zannes J.D.", "age": 68, "title": "Founder, President, CEO & Director", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 327157, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Xavier T. Reveles M.S.", "age": 54, "title": "Chief Operating Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William  Bauta Ph.D.", "title": "Chief Science Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy P. Zannes J.D.", "age": 71, "title": "Executive VP, Secretary & General Counsel", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Julie Anne Overton", "title": "Director of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dallas J. Coleman", "title": "Vice President of sales", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gordon  Downie M.D., Ph.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.2549, "open": 0.2411, "dayLow": 0.2402, "dayHigh": 0.2799, "regularMarketPreviousClose": 0.2549, "regularMarketOpen": 0.2411, "regularMarketDayLow": 0.2402, "regularMarketDayHigh": 0.2799, "payoutRatio": 0.0, "beta": 2.543, "forwardPE": -0.45, "volume": 21063191, "regularMarketVolume": 21063191, "averageVolume": 4804530, "averageVolume10days": 2764890, "averageDailyVolume10Day": 2764890, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 7983522, "fiftyTwoWeekLow": 0.164, "fiftyTwoWeekHigh": 2.259, "priceToSalesTrailing12Months": 1.0393778, "fiftyDayAverage": 0.2862, "twoHundredDayAverage": 0.51079, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 7477293, "profitMargins": -1.52179, "floatShares": 22864781, "sharesOutstanding": 29568600, "sharesShort": 1070905, "sharesShortPriorMonth": 1134850, "sharesShortPreviousMonthDate": 1753920000, "dateShortInterest": 1756425600, "sharesPercentSharesOut": 0.036199998, "heldPercentInsiders": 0.18887, "heldPercentInstitutions": 0.01461, "shortRatio": 2.28, "shortPercentOfFloat": 0.040999997, "impliedSharesOutstanding": 29568600, "bookValue": -0.076, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -11688941, "trailingEps": -0.57, "forwardEps": -0.6, "enterpriseToRevenue": 0.973, "enterpriseToEbitda": -0.788, "52WeekChange": -0.8439306, "SandP52WeekChange": 0.16885936, "quoteType": "EQUITY", "currentPrice": 0.27, "recommendationKey": "none", "totalCash": 802835, "totalCashPerShare": 0.028, "ebitda": -9490369, "totalDebt": 669997, "quickRatio": 0.473, "currentRatio": 0.645, "totalRevenue": 7681059, "revenuePerShare": 0.455, "returnOnAssets": -1.10268, "returnOnEquity": -18.0245, "grossProfits": 2294273, "freeCashflow": -3465642, "operatingCashflow": -7675376, "revenueGrowth": -0.471, "grossMargins": 0.29869, "ebitdaMargins": -1.23555, "operatingMargins": -1.9815601, "financialCurrency": "USD", "symbol": "BIAF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "regularMarketChangePercent": 5.92389, "regularMarketPrice": 0.27, "corporateActions": [], "postMarketTime": 1757721582, "regularMarketTime": 1757707200, "shortName": "bioAffinity Technologies, Inc.", "longName": "bioAffinity Technologies, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1662039000000, "postMarketChangePercent": 25.9259, "postMarketPrice": 0.34, "postMarketChange": 0.07, "regularMarketChange": 0.0151, "regularMarketDayRange": "0.2402 - 0.2799", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 4804530, "fiftyTwoWeekLowChange": 0.106000006, "fiftyTwoWeekLowChangePercent": 0.6463415, "fiftyTwoWeekRange": "0.164 - 2.259", "fiftyTwoWeekHighChange": -1.9890001, "fiftyTwoWeekHighChangePercent": -0.8804781, "fiftyTwoWeekChangePercent": -84.39306, "earningsTimestampStart": 1755174600, "earningsTimestampEnd": 1755174600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.57, "epsForward": -0.6, "epsCurrentYear": -0.48, "priceEpsCurrentYear": -0.56250006, "fiftyDayAverageChange": -0.016199976, "fiftyDayAverageChangePercent": -0.056603692, "twoHundredDayAverageChange": -0.24078998, "twoHundredDayAverageChangePercent": -0.471407, "priceToBook": -3.5526319, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-08-25", "cryptoTradeable": false, "exchange": "NCM", "messageBoardId": "finmb_423045573", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "bioAffinity", "trailingPegRatio": null, "__fetch_time": "2025-09-13"}]